10.3205/10KIT139
Bélard, S.
S.
Bélard
Issifou, S.
S.
Issifou
Ramadhani, N.
N.
Ramadhani
Kremsner, P.G.
P.G.
Kremsner
Mordmüller, B.
B.
Mordmüller
Phase 1b randomized controlled double blind trial to evaluate the safety and immunogenicity of GMZ2 malaria vaccine candidate in healthy Gabonese children aged 1 to 5 years
German Medical Science GMS Publishing House
2010
ConferencePaper
610 Medical sciences; Medicine
Deutsche Gesellschaft Für Infektiologie|Deutsche AIDS-Gesellschaft|Deutsche Gesellschaft Für Tropenmedizin Und Internationale Gesundheit|Paul-Ehrlich-Gesellschaft Für Chemotherapie
2010-06-02
2010
en
urn:nbn:de:0183-10kit1397
10kit139
text/html
10. Kongress für Infektionskrankheiten und Tropenmedizin (KIT 2010)
Background: Malaria is still a major health thread in Sub-Saharan Africa. An effective vaccine could be a sustainable control measure easy to integrate into health infrastructures such as the extended program on immunization. The malaria vaccine candidate GMZ2 is a recombinant fusion protein of conserved[for full text, please go to the a.m. URL]
10. Kongress für Infektionskrankheiten und Tropenmedizin (KIT 2010)